Abstract Details
|
Ashutosh Mahapatra, MD
(Washington Univeristy School of Medicine, Department of Neurology)
PRESENTER |
No disclosure on file |
| Fadar O. Otite, MD (SUNY Upstate Medical University) | Dr. Otite has nothing to disclose. |
| Nirav Bhatt, MD (University of Pittsburgh) | Dr. Bhatt has nothing to disclose. |
| Priyank Khandelwal, MD | Dr. Khandelwal has nothing to disclose. |
| Amer Malik, MD (University of Miami Miller School of Medicine) | Dr. Malik has nothing to disclose. |
| Seemant Chaturvedi, MD, FAHA, FAAN (University of Maryland) | Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS. |
| Ralph L. Sacco, MD, MS, FAHA | Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care. |
| Jose G. Romano, MD, FAAN (University of Miami, Miller School of Medicine) | Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI. |